Table 1.
Socio-economic and clinical information of Schizophrenia, Bipolar, and Control groups
| Demographic Characteristics | Schizophrenia | Bipolar Disorder | Control | p Value S x (B + C) |
|---|---|---|---|---|
| Age (years) | 14.64 ± 2.57 | 15.30 ± 3.77 | 15.43 ± 3.55 | 0.5837 |
| Family Income (US$ per month) | 326.14 ± 190.58 | 297.50 ± 166.94 | 368.42 ± 151.76 | 0.3746 |
| Sex | ||||
| Male | 82% | 27% | 45% | 0.0542 |
| Female | 18% | 73% | 55% | |
| Years of Education (years) | 5.73 ± 2.34 | 6.40 ± 3.77 | 8.05 ± 2.77 | 0.0810 |
| Psychiatric Assessment | Schizophrenia | Bipolar Disorder | p Value: S x B | |
| Medication | ||||
| Typical Antipsychotic | 55% | 60% | 0.8008 | |
| Atypical Antipsychotic | 82% | 40% | 0.0487 | |
| Mood Stabilizer | 9% | 70% | 0.0041 | |
| Benzodiazepine | 9% | 10% | 0.9435 | |
| Antidepressants | 9% | 20% | 0.4755 | |
| Disease Duration (days) | 339.36 ± 244.80 | 370.60 ± 306.08 | 1 |
Mean ± standard deviation of age in years, family income in USD per month, educational level in years, disease duration in days. Shown are the percentage of male and female subjects per group, and the percentage of subjects under specific types of medication. P values of Wilcoxon–Ranksum test or Chi-square test between Schizophrenia vs. Bipolar and Control groups (general information), or Schizophrenia vs. Bipolar group (clinical information). Group label according to diagnosis established after 6 months of follow-up